iShares Trust - iShares Future Exponential Technologies ETF

NasdaqGM:XT Stock Report

Market Cap: US$3.9b

iShares Trust - iShares Future Exponential Technologies ETF Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for iShares Trust - iShares Future Exponential Technologies ETF.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Capital Markets earnings growth12.0%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

None

Last updatedn/a

Recent future growth updates

No updates

Recent updates

Seeking Alpha • Apr 10

XT: More Sensitive Than General Market To Cost Of Capital Changes

Summary The iShares Future Exponential Technologies ETF is highly sensitive to cost of capital shifts, driven by its tech and disruptor focus, also with a lot of high-multiple healthcare. XT's global diversification does not mitigate its vulnerability to rising rates and geopolitical risks, especially from the Iran conflict, which is having a global upward cost of capital shift effect. XT is less concentrated in mega-cap US tech than IVV, but its higher IT and healthcare exposure increases sensitivity to inflation and capital costs and maintains sensitivity to overbuild risks. We see more risks than supports for XT, given fragile geopolitics and amplified yield curve sensitivity. Lower multiple alternatives in equity markets often present less cost of capital sensitivity. Read the full article on Seeking Alpha
Seeking Alpha • Oct 06

XT: An Undervalued Portfolio Of Innovative Global Tech Stocks

Summary iShares Exponential Technologies ETF focuses on companies driving technological innovation across various sectors, offering diversified exposure to high-growth potential industries. The ETF's investment thesis is centered on capturing the growth of exponential technologies, including AI, robotics, and biotechnology, which are expected to transform industries. The fund looks appealing due to its diversified portfolio, evidential capacity to out-perform (albeit not since January 2021), and alignment with long-term technological trends. At present, XT has clear potential for a high IRR, with the potential for returns of circa 11% annualized over the next five years. Read the full article on Seeking Alpha
Seeking Alpha • Jun 07

XT Will Likely Continue Lagging The Broader IT Sector

Summary iShares Exponential Technologies ETF is a hold due to multiple risk factors outweighing its returns along with a relatively high expense ratio. XT lacks holdings with strong fundamentals and diversified revenue streams compared to peer tech funds, particularly Vanguard's VGT. XT also includes foreign tech holdings in emerging markets, representing geopolitical risks. Read the full article on Seeking Alpha
Seeking Alpha • Mar 10

XT: Still Beating ARKK At Its Own Game, Upgrade To Buy For Possible Moonshot

Summary iShares Exponential Technologies ETF is a go-to holding due to market volatility and potential for high returns. I prefer XT to the ARK Innovation ETF, given its smoother path due to a more diversified and passive/indexed approach. XT's lower volatility and diversified portfolio make it a buy, with potential for a price increase to its 2022 high and beyond. Read the full article on Seeking Alpha
Seeking Alpha • Aug 07

XT: We're Going To Think Twice About This ETF

XT is pretty interesting and tackles an area of the market that has received flak in the latest sell-offs. However, we have some concerns about approaching emerging technologies with ETFs. Also the fund isn't that discounted despite expected reflexivity effects. Might get better bets with specific stocks. The iShares Exponential Technologies ETF (XT) might seem broadly interesting at first, but we have some misgivings about the concept of investing in ETFs of higher risk businesses. Moreover, we are surprised by how well the ETF has done all things considered, and worry that some latent effects might still hit it. Otherwise, we are pretty convinced of the appeal of tech in the current market, and feel that in general it should be studied by retail investors. But we would think twice about XT. Quick Breakdown First let's discuss some of the features of XT. The mandate is to build a portfolio that weights towards a decent amount of emerging markets and emerging technologies that follow nine key themes. XT Nine Areas of Focus (iShares.com) The themes listed above are pretty basic to be honest. We all know of the potential in these fields, and in the majority of cases the value of things like cloud computing have already been realised, at least in terms of priced in value, by large corporations through already profitable operations. Essentially, what XT is doing is allocating to all the sexiest ideas in investing that VCs would typically be focusing on. As mentioned it's not all US markets with only 62% allocation, which is nice because foreign markets typically don't value tech nearly as highly as the US does, and it's mostly tech but also some healthcare exposures, especially biotechs. The fee is below 0.5%, which isn't bad relative to some of these more 'exciting' ETFs. The fact sheet says that it's cheaper than 91% of ETFs in its category, but this should be taken with a grain of salt because they decide the categories. What matters is many iShares ETFs are around 0.4%, so just below 0.5% isn't bad relatively. ETFs and Exponential Technologies However, we have some comments about the ETF. The first is that the kinds of businesses it invests in, especially in healthcare, are stocks that depend reflexively on the equity capital market conditions. If their stocks decline, the cost of their financing rises. This is obviously bad because in unstable markets like the current one, where rates will have to rise a lot more to deal with inflation, because it causes vicious spirals.

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as iShares Trust - iShares Future Exponential Technologies ETF has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

NasdaqGM:XT - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if XT's forecast earnings growth is above the savings rate (3.5%).

Earnings vs Market: Insufficient data to determine if XT's earnings are forecast to grow faster than the US market

High Growth Earnings: Insufficient data to determine if XT's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if XT's revenue is forecast to grow faster than the US market.

High Growth Revenue: Insufficient data to determine if XT's revenue is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if XT's Return on Equity is forecast to be high in 3 years time

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/06/16 06:39
End of Day Share Price 2026/06/15 00:00
EarningsN/A
Annual EarningsN/A

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

iShares Trust - iShares Future Exponential Technologies ETF is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.